Literature DB >> 31589953

More systematic reviews were registered in PROSPERO each year, but few records' status was up-to-date.

Tanja Rombey1, Katharina Doni2, Falk Hoffmann3, Dawid Pieper2, Katharina Allers3.   

Abstract

OBJECTIVES: To determine the proportion of systematic reviews (SRs) registered in PROSPERO and explore differences between publication years, review focus, and country. Secondary objectives were (1) to compare the characteristics of registered and nonregistered SRs and (2) to assess the up-to-dateness of the PROSPERO records' status. STUDY DESIGN AND
SETTING: In November 2018, we searched PubMed for SRs that were eligible for registration in PROSPERO. We included a random sample of n = 500 SRs. Data were analyzed descriptively.
RESULTS: Overall, 76 (15.2%) of the included SRs had been registered in PROSPERO. This proportion has increased with each year, up to 31.6% (36/114) in 2018. It did not notably differ depending on the reviews' focus. SRs from the United States or China were generally registered less frequently and SRs from Australia or Canada more frequently. Registered and nonregistered SRs did not differ regarding the number of authors or the time from submission to publication or from search to submission and publication. We could analyze 75 PROSPERO records, of which 63 (84.0%) were not up-to-date. Most SRs (49/75; 65.3%) were still listed as "ongoing."
CONCLUSION: More SRs were registered in PROSPERO each year, but only few records' status was up-to-date.
Copyright © 2019 Elsevier Inc. All rights reserved.

Keywords:  Meta-analysis; Methodological research; PROSPERO; Registration; Systematic review; Transparency

Year:  2019        PMID: 31589953     DOI: 10.1016/j.jclinepi.2019.09.026

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Strengthening literature search strategies for systematic reviews reporting population health in the Middle East and North Africa: A meta-research study.

Authors:  Karima Chaabna; Sohaila Cheema; Amit Abraham; Ravinder Mamtani
Journal:  J Evid Based Med       Date:  2020-05-24

Review 2.  Chinese Medicine as an Adjunctive Treatment for Gastric Cancer: Methodological Investigation of meta-Analyses and Evidence Map.

Authors:  Cuncun Lu; Lixin Ke; Jieyun Li; Shuilin Wu; Lufang Feng; Youyou Wang; Alexios Fotios A Mentis; Peng Xu; Xiaoxiao Zhao; Kehu Yang
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

3.  Where to prospectively register a systematic review.

Authors:  Dawid Pieper; Tanja Rombey
Journal:  Syst Rev       Date:  2022-01-08

4.  Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses.

Authors:  Khalid El Bairi; Ouissam Al Jarroudi; Said Afqir
Journal:  Front Oncol       Date:  2021-09-23       Impact factor: 6.244

Review 5.  PROSPERO's systematic review protocols of traditional Chinese medicine for COVID-19: An overview.

Authors:  Haiyin Hu; Zhaochen Ji; Chaonan Feng; Wentai Pang; Zhe Chen; Junhua Zhang; Hui Wang
Journal:  Integr Med Res       Date:  2021-09-08

6.  The score after 10 years of registration of systematic review protocols.

Authors:  Kim van der Braak; Mona Ghannad; Claudia Orelio; Pauline Heus; Johanna A A Damen; René Spijker; Karen Robinson; Hans Lund; Lotty Hooft
Journal:  Syst Rev       Date:  2022-09-05

7.  Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration.

Authors:  Jérémie F Cohen; Jonathan J Deeks; Lotty Hooft; Jean-Paul Salameh; Daniël A Korevaar; Constantine Gatsonis; Sally Hopewell; Harriet A Hunt; Chris J Hyde; Mariska M Leeflang; Petra Macaskill; Trevor A McGrath; David Moher; Johannes B Reitsma; Anne W S Rutjes; Yemisi Takwoingi; Marcello Tonelli; Penny Whiting; Brian H Willis; Brett Thombs; Patrick M Bossuyt; Matthew D F McInnes
Journal:  BMJ       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.